BGXXQ.US Bright Green Corporation

Healthcare Biotechnology USA Stocks
0.0004 USD
Close of Nov 13, 2026
0.0002 0.0500
Market cap
USD 86.0K
P/E
-
P/B
0.01x
ROE
-52.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.

Is BGXXQ.US undervalued?

Graham number

The Graham number of Bright Green Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bright Green Corporation fundamental analysis

No fundamental analysis for Bright Green Corporation yet.

Bright Green Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bright Green Corporation

Bright Green Corporation produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products are used in research, manufacturing, and export, as well as for production of medical cannabis products and preparations. The company was incorporated in 2019 and is based in Grants, New Mexico. On February 22, 2025, Bright Green Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for …

Full company profile